Stay updated with breaking news from Rick Baehner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exact Sciences Corporation (NASDAQ: EXAS) shares are trading higher Wednesday, and the stock has gained over 8% in the past month. Here's a look at the latest Exact Sciences news: What To Know:
There is a prognostic impact of clinical and immunohistochemistry markers.
The Madison-based company plans to seek approval for an updated Cologuard stool test and launch a blood test for residual cancer by the end of this year.
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, announced today that it will present 15...
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today shared initial clinical validation data...